Atriventricular Septal Defect (AVSD)

Written By

Team Ayadi

Key Takeaways

Atrioventricular Septal Defect (AVSD) is a congenital heart defect involving abnormal atrial and ventricular septa and a common atrioventricular valve.
It causes mixing of oxygenated and deoxygenated blood, often leading to heart enlargement and increased pulmonary blood flow.
Commonly associated with Down syndrome, AVSD presents symptoms like poor feeding, fatigue, and breathing difficulties in infants.
Diagnosis is typically confirmed through echocardiography, with early detection crucial to prevent heart failure and other complications.
Treatment usually involves surgical repair between 3-6 months of age, with a high success rate of around 95%.

Atrioventricular Septal Defect (AVSD), a formidable congenital anomaly, emerges as a critical cardiac condition characterized by malformations in the atrial and ventricular septa, which profoundly disrupt normal blood flow and impair heart function. As you confront this diagnosis, whether for yourself or a loved one, understanding the gravity of AVSD becomes paramount, since it alters the very architecture of the heart, creating abnormal communications between its chambers. This defect, often present from birth, challenges the heart’s ability to efficiently pump oxygenated blood, setting the stage for a cascade of physiological complications that demand your immediate attention and informed action.

You’ll likely notice the impact of AVSD early on, as symptoms manifest within the first weeks of life, mimicking the distressing signs of heart failure. Imagine observing a newborn struggling with a lack of appetite, persistent fatigue, or pale skin—indicators that the heart isn’t coping with the increased workload caused by aberrant blood flow. Poor weight gain, wheezing, and breathing difficulties further complicate the picture, signaling that the heart and lungs are under siege. Medical experts, such as pediatric cardiologists at renowned institutions like Fortis Escorts Heart Institute in India, emphasize that these symptoms stem from the heart’s enlargement, a direct result of excessive blood flow straining its chambers, as documented in numerous clinical studies. Given the high prevalence of congenital heart defects in India, with an estimated birth prevalence of 8–12 per 1000 live births, early diagnosis and intervention are critical to improving outcomes for AVSD patients.

Moreover, you must brace for potential complications that extend beyond the heart itself, as AVSD often precipitates respiratory issues due to surplus blood flooding the lungs, fostering recurrent infections. Pulmonary hypertension, driven by a weakened left ventricle, also looms as a threat, elevating blood pressure in the lungs and risking long-term damage. As you navigate this condition, consider the insights of specialists at Medanta Hospital, who underscore the urgency of recognizing these risks to mitigate irreversible harm. Surgery is often recommended within the first year of life to prevent severe complications and ensure proper heart function within first year. While the path forward involves complex interventions, understanding AVSD’s profound effects equips you to engage with healthcare providers effectively. Institutions like Marengo Asia Hospitals stand ready to offer surgical solutions, ensuring that, with timely action, you can address this critical defect and safeguard future health outcomes against its relentless challenges.

Overview

Atrioventricular Septal Defect (AVSD) is a congenital heart malformation characterized by defects in the septa that separate the heart’s chambers, resulting in holes where walls should be, and abnormalities in the atrioventricular valves. This condition, which can present as a complete or incomplete defect, disrupts normal blood flow, often leading to increased pulmonary blood flow and heart enlargement. Treatment for AVSD typically involves surgical intervention to repair the septal defects and correct valve abnormalities, with the goal of restoring proper heart function and preventing long-term complications such as heart failure or Eisenmenger syndrome. In some cases, medication may be used to manage symptoms before surgery. If left untreated, AVSD can cause the heart to work harder, increasing the risk of high blood pressure in the lungs pulmonary hypertension. This treatment is essential for individuals diagnosed with AVSD, particularly infants and children, including those with associated conditions like Down syndrome, to guarantee proper heart development and prevent life-threatening complications if left untreated. AVSD is often associated with genetic conditions, with a strong link to Down syndrome.

Treatment Details and Key Information

Atrioventricular septal defect (AVSD) treatment in major corporate hospitals in India, such as Apollo, Fortis, and Max Healthcare, offers advanced care for foreign patients with a focus on surgical intervention as the primary approach. These hospitals provide complete treatment packages that include pre-surgical assessments, state-of-the-art surgical facilities, and post-operative care, often with dedicated international patient coordinators to assist with travel, visas, and language barriers. The typical hospital stay for AVSD surgery ranges from 7 to 14 days, depending on the complexity of the case and the patient’s recovery progress, while total recovery time can extend from 6 to 12 weeks, involving rehabilitation and follow-up care. The surgical procedure itself usually takes 4 to 6 hours, often performed under heart/lung bypass to support circulation during repair. Treatment options include traditional open-heart surgery and, in select cases, minimally invasive or robotic-assisted surgery. Open-heart surgery, the most common approach, involves patch placement and valve repair with a high success rate of around 95%, though it requires a longer recovery period and carries risks like abnormal heart rhythms or valve leakage. Additionally, the choice of procedure often depends on the size of the defect and the presence of other heart issues, as larger defects typically require more extensive surgical intervention. Robotic or minimally invasive techniques, available in top-tier hospitals, offer smaller incisions, reduced pain, and quicker recovery, but they are more expensive, may not be suitable for complex defects, and require highly specialized surgical expertise. Additionally, surgery for AVSD often involves the use of patches to close holes in the heart wall, which integrate over time into the heart structure.

Key Benefits & Advantages

Atrioventricular Septal Defect (AVSD) repair is a highly effective treatment option, and choosing this procedure in India offers numerous benefits. India is renowned for its advanced cardiac care facilities, skilled surgeons, and cutting-edge technology, often at a fraction of the cost compared to Western countries. The success rates for AVSD repair in India are impressive, with high rates of successful outcomes in both children and adults, thanks to modern surgical techniques and thorough post-operative care. Early intervention in India helps prevent severe complications like pulmonary hypertension and heart failure, while also improving heart function, exercise capacity, and overall quality of life. Additionally, the shorter recovery periods and low complication rates make India an attractive destination for this life-changing procedure.

Country	Average Cost of AVSD Repair (USD)	Affordability Index	Key Notes
India	5,000 – 8,000	High	Low cost, high success rates, advanced care
United States	50,000 – 100,000	Low	High cost, advanced technology
United Kingdom	30,000 – 60,000	Moderate	High cost, long waiting times
Singapore	15,000 – 25,000	Moderate	Good facilities, higher cost than India
Thailand	8,000 – 12,000	High	Affordable, growing medical tourism

Treatment Process

The treatment process for Atrioventricular Septal Defect (AVSD) primarily involves a surgical approach, as it is the most effective way to correct the defect. The process begins with a thorough diagnosis, often through echocardiography, to assess the specific type and severity of the AVSD, along with any associated heart issues. Once surgery is deemed necessary, typically between 3 to 6 months of age depending on the infant’s health and size, preoperative preparations are initiated. These include close monitoring of the infant’s condition, administering medications to manage heart failure symptoms, and providing nutritional support to secure adequate growth and strength for surgery. Families are also educated and supported by the medical team during this period to help manage the child’s condition. The surgery itself is a complex procedure tailored to the individual defect; it generally involves closing holes in the heart walls with patches and repairing or replacing defective valves to secure proper blood flow. In cases of complete AVSD, the common valve is often divided into two separate valves. The timing of surgery is critical and is performed as soon as possible to prevent lung damage from excessive blood flow, with a multidisciplinary team of specialists collaborating to optimize outcomes.

Expected Outcomes

Patients with atrioventricular septal defect (AVSD) can expect significant improvements in health and quality of life following surgical repair, typically performed within the first year of life. Successful surgery often results in symptom reduction, including alleviation of congestive heart failure and pulmonary hypertension, improved exercise tolerance, and support for normal growth and development. Long-term survival rates are promising, with approximately 88% survival at five years, 82-91.3% at ten years, and around 75.9% at fifteen years post-surgery, though outcomes can vary based on factors like age at repair, associated conditions, and surgical techniques. Advances in surgical methods and postoperative care have further enhanced these success rates and reduced complication risks. However, potential long-term risks include valve leakage requiring reoperation, arrhythmias, and, in rare cases, the need for mechanical circulatory support, emphasizing the importance of ongoing monitoring and care.

After-Treatment Care & Recovery

After undergoing treatment for atrioventricular septal defect (AVSD), patients require thorough after-treatment care to secure a smooth recovery. This includes a typical stay of 2 to 4 days in the intensive care unit, followed by additional days in the hospital for monitoring essential signs and heart function. Medications may be prescribed to manage symptoms or prevent complications, while regular follow-up appointments with a cardiologist are essential to assess healing and detect any issues through imaging tests. Physical rehabilitation, such as tailored physiotherapy or exercise programs, may be recommended to rebuild strength, with guidance on safe activity levels. During the recovery phase, precautions such as avoiding extreme altitude changes and monitoring for signs of infection or valve dysfunction are critical. Lifestyle adjustments play an essential role in long-term recovery, including adopting a heart-healthy diet, maintaining a balanced routine, and avoiding stressors that could impact heart health. Psychological support may also be beneficial to address anxiety or emotional challenges during this period.

References

Weekly Newsletter

No spam. Just the latest releases and tips, interesting articles, and exclusive interviews in your inbox every week.

Your information is protected by us. Read our privacy policy

Search site